| CTRI Number |
CTRI/2025/11/097552 [Registered on: 17/11/2025] Trial Registered Prospectively |
| Last Modified On: |
13/12/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry |
| Study Design |
Randomized, Crossover Trial |
|
Public Title of Study
|
A study to assess and compare the effectiveness of headset-based passive distraction (HBPD) using virtual reality with headset-based interactive distraction (HBID) using mixed reality on minimizing dental anxiety and pain in children during intraoral injection. |
|
Scientific Title of Study
|
Effect of headset-based distraction using passive virtual reality and interactive mixed reality on dental anxiety in children: a split-mouth randomized cross-over clinical trial. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
URVI BHATIA |
| Designation |
POST GRADUATE STUDENT |
| Affiliation |
UNIVERSITY COLLEGE OF MEDICAL SCINECES |
| Address |
248, DENTAL OPD, SECOND FLOOR, OPD BUILDING, GURU TEG BAHADUR HOSPITAL, NEW DELHI
East DELHI 110095 India |
| Phone |
9999745735 |
| Fax |
|
| Email |
urvibhatia.1998@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
URVI BHATIA |
| Designation |
POST GRADUATE STUDENT |
| Affiliation |
UNIVERSITY COLLEGE OF MEDICAL SCINECES |
| Address |
248, DENTAL OPD, SECOND FLOOR, OPD BUILDING, GURU TEG BAHADUR HOSPITAL, NEW DELHI
East DELHI 110095 India |
| Phone |
9999745735 |
| Fax |
|
| Email |
urvibhatia.1998@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
URVI BHATIA |
| Designation |
POST GRADUATE STUDENT |
| Affiliation |
UNIVERSITY COLLEGE OF MEDICAL SCINECES |
| Address |
248, DENTAL OPD, SECOND FLOOR, OPD BUILDING, GURU TEG BAHADUR HOSPITAL, NEW DELHI
East DELHI 110095 India |
| Phone |
9999745735 |
| Fax |
|
| Email |
urvibhatia.1998@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
UNIVERSITY COLLEGE OF MEDICAL SCIENCES |
| Address |
UCMS & GTB HOSPITAL, NEW DELHI 110095 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| URVI BHATIA |
UCMS and GURU TEG BAHADUR HOSPITAL |
UCMS & GTB HOSPITAL, NEW DELHI 110095 East DELHI |
9999745735
urvibhatia.1998@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE- HUMAN RESEARCH |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
healthy children requiring routine dental treatment |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Group HBID: Headset based interactive distraction (HBID) using mixed reality. |
HEADSET WILL BE USED TO PLAY GAME DURING DENTAL TREATMENT |
| Comparator Agent |
Group HBPD: Headset based passive distraction (HBPD) using virtual reality. |
HEADSET WILL BE USED TO WATCH A VIDEO DURING DENTAL TREATMENT |
|
|
Inclusion Criteria
|
| Age From |
8.00 Day(s) |
| Age To |
12.00 Day(s) |
| Gender |
Both |
| Details |
INCLUSION CRITERIA:
1. Children aged 8-12 years of both sexes.
2. Children requiring dental treatment in the mandibular arch under local anesthesia.
3. Children belonging to American Society of Anesthesiologists (ASA) category I.
4. Children belonging to Frankl Behavior Rating of 2 (negative) or 3 (positive).
5. Children whose parents agree to take part in the study.
|
|
| ExclusionCriteria |
| Details |
EXCLUSION CRITERIA:
1. Children having undergone any previous dental treatment.
2. Children allergic to local anesthesia (confirmed through a patch test).
3. Children with known intellectual or developmental disabilities.
4. Children having undergone any previous pharmacological behavior management.
5. Children requiring emergency dental care.
6. Children with a known history of epilepsy.
7. Children with known visual impairment.
8. Children with injuries to head/face that would prohibit wearing the headset.
9. Children with any known skin infection.
10. Children with a known history of vertigo and claustrophobia.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To assess and compare the effectiveness of HBPD using virtual reality with HBID using mixed reality on dental anxiety using an objective scale and physiological parameters for children scheduled to undergo dental treatment which requires intraoral injection. |
IN THE WAITING AREA, BEFORE START OF TREATMENT, DURING TREATMENT AND AFTER TREATMENT |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To assess & compare the effectiveness of HBPD using virtual reality with HBID using mixed reality on pain for children scheduled to undergo dental treatment. |
AFTER TREATMENT COMPLETION |
| To assess and compare the effectiveness of HBPD using virtual reality with HBID using mixed reality on behaviour at the end of dental treatment. |
BEFORE AND AFTER TREATMENT |
| To evaluate the acceptability and feasibility of the headset used by children, as assessed by parents at the end of treatment. |
AFTER TREATMENT COMPLETION |
| To evaluate comfort of the headset used through a researcher-based questionnaire in both the groups, as answered by children at the end of treatment. |
AFTER TREATMENT COMPLETION |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
30/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
Modification(s)
|
not yet published |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response (Others) - NIL
- For how long will this data be available start date provided 01-06-2025 and end date provided 30-09-2026?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
Modification(s)
|
METHOD: Patients will be recruited from the outpatient setting of Department of Dentistry (Unit of Pediatric and Preventive Dentistry), University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi. The study will be conducted as a split-mouth study. A total of 100 systemically healthy subjects in the age group of 8-12 years requiring dental treatment in the mandibular arch which involves administration of intraoral injection will be included in the study. After satisfying the inclusion and exclusion criteria, subjects will be randomly assigned to one of the following two groups using computer-generated random table. Group HBPD: Headset based passive distraction (HBPD) using virtual reality. Group HBID: Headset based interactive distraction (HBID) using mixed reality. Procedure with timing of measurement of primary and secondary objectives: PRIMARY OUTCOME MEASURES | Anxiety | Pain | Vehnam clinical anxiety rating scale | Physiological parameters | Wong baker faces pain rating scale | Sound, Eye and Motor scale |
Anxiety measurement: Baseline anxiety levels (A) will be measured in all patients in the waiting area before random allocation in any of the two groups at baseline dental examination visit (V0). After dividing patients into either HBPD or HBID groups using a computer generated random table and before the start of any procedure, an operator will record preoperative anxiety levels (A1) using Venham Clinical Anxiety Rating Scale (VCARS). Anxiety will again be measured by the same operator after dental treatment completion and removal of all interventions in both the groups using the Venham Clinical Anxiety Rating Scale (A2). Treatment phase | Measurement of anxiety through physiological parameters | Pre-treatment phase | Before the start of procedure, the patient will be seated comfortably and in a relaxed, isolated environment. 5 minutes preceding the application of any intervention, heart rate (H1) and oxygen saturation (O1) will be measured as preoperative parameters. | Treatment phase | Immediately after administration of intraoral injection, heart rate (H2) and oxygen saturation (O2) will be measured as intraoperative parameters. | Post-treatment phase | Post-operative heart rate (H3) and oxygen saturation (O3) will be measured 5 minutes after the procedure has been completed. |
The pain measurement will be done immediately after administration of intraoral injection. Two scales will be used for measurement of pain: a self-reported scale (Wong Baker FACES Pain Rating Scale) and a non-self-reported scale (Sound, Eye, Motor scale). SECONDARY OUTCOME MEASURES | Behaviour | Acceptability and feasibility of headset | Questionnaire | Venham behaviour rating scale | Visual Analogue Scale | Researcher-based questionnaire |
Behaviour assessment: The behaviour rating scale ‘Venham Behaviour Rating Scale’ for overall behaviour will be used for assessment of behaviour at the end of the treatment procedure. It is a non-self-reported scale with scores ranging from 0-5. The operating dentist will assess the behaviour after each treatment visit. Acceptability and feasibility of headset: Visual Analogue Scale (VAS) will be used for assessment of acceptability and feasibility of headset worn by children, as measured by parents. This will be done after the completion of both dental treatment visits (V2). Researcher-based questionnaire (self-designed): A questionnaire regarding the comfort and acceptability of the Meta Quest 3S headset will be given to the child to answer. The questionnaire will be presented in English or Hindi based on the language that the child prefers. |